Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tegileridine vs morphine for postoperative intravenous analgesia after oral tumor surgery
ChiCTR2600119219Phase 4Not yet recruiting
- Sponsor
- Shanghai Ninth People's Hospital
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of tegileridine in postoperative pain (2 arms), sponsored by Shanghai Ninth People's Hospital. Primary endpoint: Resting summed pain intensity difference over 24 hours (rSPID24). Planned start Feb 2026; status: not yet recruiting.
02
Drugs
tegileridine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2600119219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600119219.